Pembrolizumab: patient selection or immune intensification?
Crossref DOI link: https://doi.org/10.1038/s41585-018-0076-z
Published Online: 2018-08-21
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Madan, Ravi A.
Gulley, James L. http://orcid.org/0000-0002-6569-2912
Text and Data Mining valid from 2018-08-21
Article History
First Online: 21 August 2018
Competing interests
: The authors declare no competing interests.